Christian Tyrchan
Christian Tyrchan
Teamleader Computational Chemistry RIA, AstraZeneca
Verified email at astrazeneca.com
TitleCited byYear
Recent developments of the chemistry development kit (CDK)-an open-source java library for chemo-and bioinformatics
C Steinbeck, C Hoppe, S Kuhn, M Floris, R Guha, EL Willighagen
Current pharmaceutical design 12 (17), 2111-2120, 2006
4522006
Generating focused molecule libraries for drug discovery with recurrent neural networks
MHS Segler, T Kogej, C Tyrchan, MP Waller
ACS central science 4 (1), 120-131, 2017
1912017
Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data
S Muresan, P Petrov, C Southan, MJ Kjellberg, T Kogej, C Tyrchan, ...
Drug Discovery Today 16 (23-24), 1019-1030, 2011
612011
Structural analysis and prediction of protein mutant stability using distance and torsion potentials: role of secondary structure and solvent accessibility
V Parthiban, MM Gromiha, C Hoppe, D Schomburg
Proteins: Structure, Function, and Bioinformatics 66 (1), 41-52, 2007
612007
Structural and conformational determinants of macrocycle cell permeability
B Over, P Matsson, C Tyrchan, P Artursson, BC Doak, MA Foley, ...
Nature chemical biology 12 (12), 1065, 2016
582016
Comparison of molecular fingerprint methods on the basis of biological profile data
A Steffen, T Kogej, C Tyrchan, O Engkvist
Journal of chemical information and modeling 49 (2), 338-347, 2009
492009
Prediction of protein thermostability with a direction‐and distance‐dependent knowledge‐based potential
C Hoppe, D Schomburg
Protein Science 14 (10), 2682-2692, 2005
442005
Physicochemical property profiles of marketed drugs, clinical candidates and bioactive compounds
C Tyrchan, N Blomberg, O Engkvist, T Kogej, S Muresan
Bioorganic & medicinal chemistry letters 19 (24), 6943-6947, 2009
352009
Follow-on drugs: how far should chemists look?
F Giordanetto, J Boström, C Tyrchan
Drug discovery today 16 (15-16), 722-732, 2011
292011
Classification and comparison of ligand-binding sites derived from grid-mapped knowledge-based potentials
C Hoppe, C Steinbeck, G Wohlfahrt
Journal of Molecular Graphics and Modelling 24 (5), 328-340, 2006
272006
Intramolecular hydrogen bond expectations in medicinal chemistry
F Giordanetto, C Tyrchan, J Ulander
ACS medicinal chemistry letters 8 (2), 139-142, 2017
262017
Annotated chemical patent corpus: a gold standard for text mining
SA Akhondi, AG Klenner, C Tyrchan, AK Manchala, K Boppana, D Lowe, ...
PloS one 9 (9), e107477, 2014
242014
Theoretical studies of chemical reactivity of metabolically activated forms of aromatic amines toward DNA
I Shamovsky, L Ripa, N Blomberg, LA Eriksson, P Hansen, C Mee, ...
Chemical research in toxicology 25 (10), 2236-2252, 2012
202012
Binding mode and induced fit predictions for prospective computational drug design
C Grebner, J Iegre, J Ulander, K Edman, A Hogner, C Tyrchan
Journal of chemical information and modeling 56 (4), 774-787, 2016
182016
Exploiting structural information in patent specifications for key compound prediction
C Tyrchan, J Boström, F Giordanetto, J Winter, S Muresan
Journal of chemical information and modeling 52 (6), 1480-1489, 2012
152012
Matched molecular pair analysis in short: algorithms, applications and limitations
C Tyrchan, E Evertsson
Computational and structural biotechnology journal 15, 86-90, 2017
132017
A comprehensive company database analysis of biological assay variability
C Kramer, G Dahl, C Tyrchan, J Ulander
Drug discovery today 21 (8), 1213-1221, 2016
132016
GPR103 Antagonists Demonstrating Anorexigenic Activity in Vivo: Design and Development of Pyrrolo[2,3-c]pyridines That Mimic the C-Terminal Arg-Phe Motif of …
J Georgsson, F Bergström, A Nordqvist, MJ Watson, CD Blundell, ...
Journal of medicinal chemistry 57 (14), 5935-5948, 2014
122014
SARConnect: a tool to interrogate the connectivity between proteins, chemical structures and activity Data
M Eriksson, I Nilsson, T Kogej, C Southan, M Johansson, C Tyrchan, ...
Molecular informatics 31 (8), 555-568, 2012
102012
Discovery of highly isoform selective orally bioavailable phosphoinositide 3-kinase (PI3K)-γ inhibitors
N Pemberton, M Mogemark, S Arlbrandt, P Bold, RJ Cox, C Gardelli, ...
Journal of medicinal chemistry 61 (12), 5435-5441, 2018
92018
The system can't perform the operation now. Try again later.
Articles 1–20